NKG2D, An NK Cell Activating Receptor on CD8+ T Cells, Plays An Essential Role In Killing Myeloma Cells

被引：0
|
作者：
Talebian, Laleh [1 ]
Meehan, Kenneth
Patey, Megan E.
Fisher, Dawn A.
Szczepiorkowski, Zbigniew [2 ]
Ernstoff, Marc
Sentman, Charles [1 ]
机构：
[1] Dartmouth Coll, Lebanon, NH 03756 USA
[2] Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03766 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：866 / 866
页数：1
相关论文
共 50 条
  • [31] IL-21 down-regulates NKG2D/DAP10 express on human NK and CD8+ T cells
    Burgess, SJ
    Marusina, AI
    Pathmanathan, I
    Borrego, F
    Coligan, JE
    JOURNAL OF IMMUNOLOGY, 2006, 176 (03): : 1490 - 1497
  • [32] Porcine cells express more than one functional ligand for the human NK cell activating receptor NKG2D
    Tran, Peter
    Christiansen, Dale
    Winterhalter, Adam
    Brooks, Andrew
    Gorrell, Mark
    Lilienfeld, Benjamin G.
    Seebach, Joerg D.
    Sandrin, Mauro
    Sharland, Alexandra
    XENOTRANSPLANTATION, 2007, 14 (05) : 457 - 457
  • [33] NKG2D defines tumor-reacting effector CD8+ T cells within tumor microenvironment
    Mojic, Marija
    Shitaoka, Kiyomi
    Ohshima, Chikako
    Ucche, Sisca
    Lyu, Fulian
    Hamana, Hiroshi
    Tahara, Hideaki
    Kishi, Hiroyuki
    Hayakawa, Yoshihiro
    CANCER SCIENCE, 2021, 112 (09) : 3484 - 3490
  • [34] IL-21 down-regulates NKG2D expression and function in human NK cells and differentially regulates NKG2D and CD28 expression on CD8+T cells
    Burgess, Steven James
    Marusina, Alina
    Borrego, Francisco
    Coligan, John
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S27 - S27
  • [35] CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis
    Lerner, Emily C. C.
    Woroniecka, Karolina I. I.
    D'Anniballe, Vincent M. M.
    Wilkinson, Daniel S. S.
    Mohan, Aditya A. A.
    Lorrey, Selena J. J.
    Waibl-Polania, Jessica
    Wachsmuth, Lucas P. P.
    Miggelbrink, Alexandra M. M.
    Jackson, Joshua D. D.
    Cui, Xiuyu
    Raj, Jude A. A.
    Tomaszewski, William H. H.
    Cook, Sarah L. L.
    Sampson, John H. H.
    Patel, Anoop P. P.
    Khasraw, Mustafa
    Gunn, Michael D. D.
    Fecci, Peter E. E.
    NATURE CANCER, 2023, 4 (09) : 1258 - +
  • [36] The NKG2D/MIC activating pathway in NK and CD8 T cells is impaired during chronic hepatitis C virus (HCV) infection
    Sene, Damien
    Abel, Michal
    Levasseur, Franck
    Caillat-Zucman, Sophie
    Cacoub, Patrice
    HEPATOLOGY, 2006, 44 (04) : 297A - 297A
  • [37] NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8+ T cells
    Whitman, Emily
    Barber, Amorette
    MOLECULAR IMMUNOLOGY, 2015, 63 (02) : 268 - 278
  • [38] Deletion of the activating NK cell receptor NKG2D accelerates rejection of cardiac allografts
    Fabritius, Cornelia
    Ritschl, Paul Viktor
    Resch, Thomas
    Roth, Mario
    Ebner, Susanne
    Guenther, Julia
    Mellitzer, Vanessa
    Anh-Vu Nguyen
    Pratschke, Johann
    Sauter, Martina
    Klingel, Karin
    Kotsch, Katja
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (12) : 3199 - 3209
  • [39] Identification and characterisation of porcine ligands for the human NK cell activating receptor NKG2D
    Tran, P
    Christiansen, D
    Sandrin, M
    Sharland, A
    IMMUNOLOGY AND CELL BIOLOGY, 2005, 83 (04): : A24 - A24
  • [40] Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 Å
    Wolan, DW
    Teyton, L
    Rudolph, MG
    Villmow, B
    Bauer, S
    Busch, DH
    Wilson, IA
    NATURE IMMUNOLOGY, 2001, 2 (03) : 248 - 254
12345